NPR Coronavirus Updates

Federal Trade Commission Cracks Down On Unproven COVID-19 Treatment

By Tom Dreisbach
Published November 12, 2020 at 1:42 PM MST
  • Facebook
  • Twitter
  • LinkedIn
  • Email

The Federal Trade Commission issued warning letters to several companies that marketed an unproven drug to treat COVID-19. Sales of the nonapproved drug, thymosin alpha-1, were first reported by NPR.

Copyright 2020 NPR

NPR Coronavirus Updates
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Tom Dreisbach
Tom Dreisbach is a correspondent on NPR's Investigations team focusing on breaking news stories.
See stories by Tom Dreisbach